NightHawk Biosciences
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
N/A
Price/Sales ratio
N/A
Earnings per Share (EPS)
$-0.46

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-3.09-2.51-0.96-1.20-1.23-1.08-0.78-3.09-2.13-0.46-0.31-1.23
Price/Sales ratio
N/AN/AN/A44.269.612.955.2329.0535.783.432.962.95
Price/Book Value ratio
1.222.514.821.711.980.561.170.730.660.270.260.56
Price/Cash Flow ratio
-4.21-3.01-1.12-1.11-2.31-0.78-1.24-3.89-1.98-3.60-2.76-0.78
Price/Free Cash Flow ratio
-4.18-2.87-1.11-1.11-2.29-0.76-1.21-3.83-1.88-0.79-0.64-2.29
Price/Earnings Growth ratio
-0.040.11-0.020.010.020.010.020.050.11-0.020.020.02
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/A-2631.11%-443.93%-180.17%-326.80%-338.90%67.27%-7.02%-0.26%-443.93%
Operating Profit Margin
N/AN/AN/A-3842.40%-877.85%-309.98%-680.39%-886.18%-1676.39%-763.89%-946.02%-309.98%
Pretax Profit Margin
N/AN/AN/A-3797.76%-869.73%-303.36%-667.06%-894.90%-1682.44%-788.34%-987.04%-303.36%
Net Profit Margin
N/AN/AN/A-3680.43%-779.08%-271.56%-668.54%-939.43%-1675.53%-733.35%-928.48%-271.56%
Effective Tax Rate
-32.99%3.11%2.19%-6.31%6.12%5.60%-0.22%-4.97%0.41%6.97%-5.01%5.60%
Return on Assets
-37.84%-74.06%-153.54%-141.33%-58.65%-41.66%-78.53%-22.29%-29.26%-42.01%-59.11%-41.66%
Return On Equity
-39.61%-100.24%-500.98%-142.94%-160.65%-51.94%-150.20%-23.82%-31.29%-59.33%-68.40%-160.65%
Return on Capital Employed
-30.05%-91.31%-335.97%-179.79%-135.41%-54.60%-118.40%-21.67%-30.47%-52.90%-72.80%-135.41%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A2.77N/A
Quick Ratio
18.545.941.795.171.135.691.8030.6720.522.652.491.13
Cash ratio
3.861.440.704.910.944.541.072.981.700.460.464.54
Days of Sales Outstanding
N/AN/AN/A87.933.561.794.1821.9411.41134.6737.473.56
Days of Inventory outstanding
N/AN/AN/AN/AN/A21.610.0045.671.28K122.21N/A21.61
Operating Cycle
N/AN/AN/A87.933.5623.414.1867.621.29K256.899.233.56
Days of Payables Outstanding
N/A95.106.23K11.3445.6321.9142.1629.66487.09252.26252.2645.63
Cash Conversion Cycle
N/AN/AN/A76.58-42.071.49-37.9737.95805.154.62-214.791.49
Debt Ratios
Debt Ratio
N/A0.170.51N/AN/A0.040.070.010.010.080.300.30
Debt Equity Ratio
N/A0.231.66N/AN/A0.050.140.010.010.120.430.43
Long-term Debt to Capitalization
N/A0.160.47N/AN/AN/A0.100.010.010.100.10N/A
Total Debt to Capitalization
N/A0.180.62N/AN/A0.050.120.010.010.110.110.11
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-116.98N/A
Cash Flow to Debt Ratio
N/A-3.62-2.58N/AN/A-13.60-6.65-11.91-19.78-0.60-0.75-0.75
Company Equity Multiplier
1.041.353.261.012.731.241.911.061.061.411.411.41
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/A-39.58-4.14-3.74-4.21-7.47-18.04-0.95-1.07-4.14
Free Cash Flow / Operating Cash Flow Ratio
1.001.041.001.001.001.021.021.011.044.524.291.00
Cash Flow Coverage Ratio
N/A-3.62-2.58N/AN/A-13.60-6.65-11.91-19.78-0.60-0.75-0.75
Short Term Coverage Ratio
N/A-24.73-5.56N/AN/A-13.60-48.27-56.92-62.41-7.20-9.00-9.00
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A